Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination

BACKGROUND: This placebo-controlled study assessed the effects of the once-daily inhaled corticosteroid (ICS) fluticasone furoate (FF) and long-acting beta(2)-agonist (LABA) vilanterol (VI) on early and late asthmatic responses (EAR/LAR) and airway hyper-responsiveness (AHR). METHODS: Patients (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, A, Bjermer, L, Quinn, D, Saggu, P, Thomas, P, Yarnall, K, Lötvall, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223930/
https://www.ncbi.nlm.nih.gov/pubmed/23924233
http://dx.doi.org/10.1111/all.12205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223930/
https://www.ncbi.nlm.nih.gov/pubmed/23924233
http://dx.doi.org/10.1111/all.12205

Ejemplares similares